Articles tagged "Kidney/liver transplantation"

2019 American Transplant Congress
Type of Induction Does Not Impact Patient or Kidney Allograft Survival in Simultaneous Liver and Kidney Transplant Recipients in the United States
S. Riad¹, N. Lim², S. Jackson³, J. Lake²
¹University of Minnesota, Minneapolis, MN, ²Medicine, University of Minnesota, Minneapolis, MN, ³Complex Care Analytics, Fairview Health Services, Minneapolis, MN
*Purpose: Induction practices vary widely in the United States for patients undergoing simultaneous liver and kidney (SLK) transplantation. We examined the impact of induction type…
2019 American Transplant Congress
Human Neutrophil Function against Pathogens in Solid Organ and Stem Cell Transplant Recipients
N. Barros, N. Alexander, Z. Dagher, S. Knooihuizen, A. Viens, A. R. Hopke, D. Irimia, M. K. Mansour
Transplant Infectious Diseases, Massachusetts General Hospital, Boston, MA
*Purpose: The effects of solid organ (SOT) and allogeneic stem cell transplantation (SCT) on the neutrophil function is not well described. In this study, we…
2019 American Transplant Congress
Iguratimod Inhibits the Donor Specific Antibodies Production and Attenuates the Antibody Mediated Rejection in Rat Kidney Transplantation
Z. Wang, M. Zheng, H. Chen, S. Li, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu
No.300 Guangzhou Road of Nanjing, Nanjing, China
*Purpose: Our study was designed to investigate the efficacy and related mechanisms of Iguratimod (T-614) in the inhibition of DSAs following kidney transplantation.*Methods: A rat…
2019 American Transplant Congress
Outcomes for Liver Transplant Recipients on Renal Replacement Therapy: Who Cannot Wait for Safety Net
A. Pita¹, N. Kaur¹, M. Lo², A. F. Sabour¹, V. Tristan¹, Y. Genyk¹, M. K. Nadim³, L. Sher¹
¹Department of Surgery, Keck Medical Center of USC, Los Angeles, CA, ²Department of Preventive Medicine, Keck Medical Center of USC, Los Angeles, CA, ³Department of Medicine, Keck Medical Center of USC, Los Angeles, CA
*Purpose: The purpose of this study is to identify risk factors for poor outcomes for liver transplant (LT) recipients on renal replacement therapy (RRT) in…
2019 American Transplant Congress
Comparing the Rate of Opportunistic Infection after Renal Transplant between Alemtuzumab and Basiliximab for Induction Immunosuppression
J. A. Seaman¹, S. G. Westphal², F. Qiu³, D. Bremers⁴, D. Florescu⁵
¹College of Medicine, University of Nebraska Medical Center, Omaha, NE, ²Internal Medicine Division of Nephrology, University of Nebraska Medical Center, Omaha, NE, ³Biostatistics, University of Nebraska Medical Center, Omaha, NE, ⁴Donate Life, Nebraska Medicine, Omaha, NE, ⁵Internal Medicine Division of Infectious Disease, University of Nebraska Medical Center, Omaha, NE
*Purpose: The aim of our study was to compare the outcomes one-year after renal transplant with a focus on opportunistic infections in patients who received…
2019 American Transplant Congress
Wide Geographic Variability in the Proportion of Donors with Cardiac Death – Lost Opportunities for Organ Donation?
E. M. Sonnenberg¹, D. S. Goldberg², J. Y. Hsu³, P. P. Reese², P. L. Abt¹
¹Department of Surgery, University of Pennsylvania, Philadelphia, PA, ²Department of Medicine, University of Pennsylvania, Philadelphia, PA, ³Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA
*Purpose: Donation after cardiac death (DCD) donors are largely not considered by organ procurement organization (OPO) metrics, as DCD donors are only counted in donor…
2019 American Transplant Congress
Sequential Liver Kidney Transplant Has Comparable Outcomes As Combined Liver Kidney Transplant Except For Ckd 5 In Patient With Cld With Ckd In Live Donor Program- Retrospective Analysis Of 2182 Cases
S. Verma, S. Naganathan, S. Gupta
Center for Liver and Biliary Sciences, Max Superspeciality hospital, New Delhi, India
*Purpose: Chronic Kidney disease (CKD) is common in patient with Chronic liver disease (CLD). It is difficult to distinguish between CKD and Hepatorenal syndrome (HRS)…
2019 American Transplant Congress
Facilitators and Barriers to Implementing the Live Donor Champion Program
A. D. Love¹, D. R. Helfer¹, S. Rasmussen¹, M. Johnson¹, J. M. Konel¹, J. R. Wellen², S. M. Nazarian³, E. King¹, D. L. Segev¹, T. Hwee¹, A. M. Cameron¹, M. L. Henderson¹, E. J. Gordon⁴, J. M. Garonzik Wang¹
¹Surgery, Johns Hopkins University, Baltimore, MD, ²Abdominal Transplant Surgery, Washington University School of Medicine, St. Louis, MO, ³Surgery, Penn Transplant Institute, Philadelphia, PA, ⁴Surgery, Northwestern Feinberg School of Medicine, Chicago, IL
*Purpose: The Live Donor Champion (LDC) Program is an intervention designed to increase kidney transplant candidate knowledge about living donor kidney transplantation (LDKT) and ability…
2019 American Transplant Congress
A Clinical Pharmacogenetic Model to Predict the Efficacy of Sirolimus during the Early Administration in Renal Transplant Recipients
Z. Wang, S. Fei, Z. Han, J. Tao, R. Tan, M. Gu
No.300 Guangzhou Road of Nanjing, Nanjing, China
*Purpose: This study was to develop a clinical pharmacogenetic model to predict the efficacy of sirolimus during the early administration in renal transplant recipients. 70…
2019 American Transplant Congress
Combined Liver and Delayed Kidney Transplantation (CLKT) Enables Similar Patient Survival as Liver Transplantation Alone (LTA): Propensity Score-Based Comparison
B. Ekser¹, C. A. Kubal¹, R. S. Mangus¹, P. Mihaylov¹, J. A. Fridell¹, L. R. Timsina¹, M. Lacerda², M. Ghabril², J. A. Powelson¹, W. C. Goggins¹
¹Transplant Division - Department of Surgery - Indiana University, Indianapolis, IN, ²Gastroenterology, Indiana University, Indianapolis, IN
*Purpose: We previously showed the positive impact of delayed KT in CLKT on patient survival compared to simultaneous KT. It is well known from the…